LORD, ABBETT & CO. LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$21,986,000
+21245.6%
901,813
+6206.4%
0.07%
Q2 2015$103,000
-98.8%
14,300
-98.9%
0.00%
-100.0%
Q3 2013$8,391,000
+294.3%
1,349,084
+187.8%
0.02%
+280.0%
Q2 2013$2,128,000468,7990.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 17,850,650$75,330,0005.64%
BVF INC/IL 6,682,711$28,201,0004.81%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,729,361$36,838,0001.49%
First Light Asset Management, LLC 530,391$2,238,0000.94%
KOPP INVESTMENT ADVISORS LLC 376,477$1,589,0000.78%
Sarissa Capital Management LP 700,000$2,954,0000.57%
Orbimed Advisors 10,689,000$45,108,0000.41%
Bedell Frazier Investment Counselling, LLC 178,971$755,0000.37%
PINNACLE ASSOCIATES LTD 3,453,487$14,574,0000.31%
Artal Group S.A. 3,710,000$15,656,0000.29%
View complete list of ARRAY BIOPHARMA INC shareholders